← All organizations

Knoll

For profitContributed to NME

Also known as: Knoll Pharmaceuticals, Germany (now Abbott)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Dec 1, 2000

Acquired by Abbott on Dec 15, 2000

Timeline

1880s

Jan 1, 1886
Knoll— Founded

1950s

Apr 14, 1955
levothyroxine— NDA Organization

2000s

Dec 15, 2000
Abbott— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

itropride

Indications

Approved for

Studied for

Dyspepsia

Marketed drugs (3)

Recent trials (1)

NCT00272103CollaboratorPhase 2/Phase 3Dec 1, 2000

Details

Founded: Ludwigshafen, DE Jan 1, 1886
First NDA: Mar 23, 1943
Last known activity: Dec 1, 2000